V1 sact_regimen
730,471 rows · 12 columns
| MERGED_REGIMEN_ID | MERGED_TUMOUR_ID | HEIGHT_AT_START_OF_REGIMEN | WEIGHT_AT_START_OF_REGIMEN | INTENT_OF_TREATMENT | DATE_DECISION_TO_TREAT | START_DATE_OF_REGIMEN | MAPPED_REGIMEN | CLINICAL_TRIAL | CHEMO_RADIATION | MERGED_PATIENT_ID | BENCHMARK_GROUP |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 330001811 | 330001033 | 1.61 | 160 | Curative (C) | 2015-02-20 | 2015-02-27 | Cisplatin 7 day | N | Y | 330007184 | CISPLATIN |
| 330001812 | 330001034 | 1.78 | 15 | Neo-adjuvant (N) | null | 2015-10-30 | Cisplatin + Docetaxel +Fluorouracil | 02 | N | 330007186 | CISPLATIN + DOCETAXEL + FLUOROURACIL |
| 330001813 | 330001035 | 1.72 | 4.2 | Neo-adjuvant (N) | 2017-04-18 | 2017-04-24 | CISPLATIN + DOCETAXEL + FLUOROURACIL | 2 | null | 330007189 | CISPLATIN + DOCETAXEL + FLUOROURACIL |
| 330001814 | 330001035 | null | null | Curative (C) | 2013-03-28 | 2013-04-18 | Cisplatin | N | Y | 330007189 | CISPLATIN |
| 330001815 | 330001036 | 1.77 | null | Neo-adjuvant (N) | 2015-07-11 | 2015-07-28 | Cisplatin + Docetaxel +Fluorouracil | null | N | 330007196 | CISPLATIN + DOCETAXEL + FLUOROURACIL |
| 330001816 | 330001036 | 1.7 | 93 | Curative (C) | 2014-10-01 | 2014-10-26 | Cisplatin 7 day | 02 | Y | 330007196 | CISPLATIN |
| 330001817 | 330001037 | null | 66 | Curative (C) | 2015-03-15 | 2015-03-16 | NB Low/Interm risk guidelines Carbo/Etop | N | N | 330007198 | NOT MATCHED |
| 330001818 | 330006562 | 1.74 | 70.6 | Curative (C) | null | 2014-05-21 | Cisplatin | N | Y | 330007200 | CISPLATIN |
| 330001819 | 330006562 | 1.7 | 93 | Curative (C) | 2016-08-18 | 2016-09-15 | Cisplatin | N | Y | 330007200 | CISPLATIN |
| 330001820 | 330006562 | null | null | Curative (C) | 2014-09-25 | 2014-09-29 | Cisplatin | N | N | 330007200 | CISPLATIN |
| 330001821 | 330001038 | 1.8 | 105.8 | Curative (C) | 2017-11-02 | 2017-11-29 | Cisplatin 7 day | 02 | Y | 330007205 | CISPLATIN |
| 330001822 | 330001039 | 1.71 | 14.8 | Curative (C) | 2013-10-29 | 2013-10-30 | Trial Unspecified | null | Y | 330007207 | TRIAL |
| 330001823 | 330001039 | 1.7 | null | null | 2015-01-27 | 2015-02-03 | Cisplatin + Docetaxel +Fluorouracil | 2 | N | 330007207 | CISPLATIN + DOCETAXEL + FLUOROURACIL |
| 330001824 | 330001040 | 1.51 | 48.4 | Palliative (P) | 2016-01-02 | 2016-01-16 | CISPLATIN + DOCETAXEL + FLUOROURACIL | 2 | N | 330007212 | CISPLATIN + DOCETAXEL + FLUOROURACIL |
| 330001826 | 330001042 | 1.63 | 69.1 | Curative (C) | 2016-01-19 | 2016-03-22 | Cisplatin | N | N | 330007214 | CISPLATIN |
| 330001827 | 330001042 | 1.78 | 5.3 | Curative (C) | 2013-12-30 | 2013-12-30 | EW EuroEwing 2012 Arm B VDC | N | N | 330007214 | TRIAL |
| 330001828 | 330001042 | 0 | 76.9 | null | 2013-04-02 | 2013-04-02 | EW EuroEwing 2012 Arm B VDC | Y | N | 330007214 | TRIAL |
| 330001829 | 330001042 | null | 54 | Curative (C) | 2012-10-18 | 2013-01-17 | NB HRNBL-1 COJEC Ind COURSE A | Y | N | 330007214 | NOT MATCHED |
| 330001830 | 330001043 | 0 | 82.7 | Curative (C) | null | 2018-02-15 | Trial Unspecified | N | N | 330007231 | TRIAL |
| 330001831 | 330001044 | 1.62 | null | Neo-adjuvant (N) | 2016-09-04 | 2016-09-21 | Cisplatin + Docetaxel +Fluorouracil | N | N | 330007232 | CISPLATIN + DOCETAXEL + FLUOROURACIL |
| 330001832 | 330006565 | null | 89 | Curative (C) | 2016-12-22 | 2016-12-30 | NB HRNBL-1 COJEC Ind COURSE A | N | N | 330007233 | NOT MATCHED |
| 330001833 | 330001045 | null | 18.7 | Adjuvant (A) | 2014-09-11 | 2014-10-06 | Cisplatin | N | Y | 330007237 | CISPLATIN |
| 330001834 | 330001046 | 1.8 | null | null | 2016-10-15 | 2016-10-15 | Cisplatin | N | Y | 330007244 | CISPLATIN |
| 330001835 | 330001046 | null | 12.8 | Neo-adjuvant (N) | 2015-06-11 | 2015-06-22 | Cisplatin + Docetaxel +Fluorouracil | N | N | 330007244 | CISPLATIN + DOCETAXEL + FLUOROURACIL |
| 330001836 | 330001047 | 1.67 | 74.4 | Curative (C) | 2014-01-05 | 2014-01-25 | CISPLATIN + DOCETAXEL + FLUOROURACIL | 02 | N | 330007247 | CISPLATIN + DOCETAXEL + FLUOROURACIL |
| 330001837 | 330001047 | null | null | Curative (C) | 2014-09-22 | 2014-09-26 | OST Euramos 1 Closed Trial - Ai | N | N | 330007247 | NOT MATCHED |
| 330001838 | 330001048 | null | 61.5 | Curative (C) | 2015-05-06 | 2015-05-10 | CNS Medbl HR POG 9031 Vinc/Cyclophos | Y | N | 330007251 | NOT MATCHED |
| 330001839 | 330001049 | null | 22.7 | Curative (C) | 2015-05-29 | 2015-05-29 | NB HRNBL-1 COJEC Ind COURSE A | Y | N | 330007256 | NOT MATCHED |
| 330001840 | 330006568 | 1.01 | null | Disease modification (D) | 2015-02-18 | 2015-02-19 | R2W trial | null | null | 330007257 | TRIAL |
| 330001841 | 330006568 | 1.8 | 83.3 | Curative (C) | 2015-01-09 | 2015-02-12 | Cisplatin | N | Y | 330007257 | CISPLATIN |
| 330001842 | 330006568 | 1.61 | 69.1 | Curative (C) | 2014-06-14 | 2014-06-15 | Cisplatin 7 day | N | N | 330007257 | CISPLATIN |
| 330001843 | 330001050 | null | null | Palliative (P) | 2014-10-15 | 2014-10-22 | Trial Unspecified | 01 | N | 330007268 | TRIAL |
| 330001844 | 330001050 | 1.69 | 89 | Neo-adjuvant (N) | 2016-10-06 | 2016-10-14 | Cisplatin + Docetaxel +Fluorouracil | 02 | N | 330007268 | CISPLATIN + DOCETAXEL + FLUOROURACIL |
| 330001845 | 330001051 | 1.65 | 86.4 | Adjuvant (A) | null | 2014-02-07 | Cisplatin 7 day | 02 | Y | 330007274 | CISPLATIN |
| 330001847 | 330001053 | 1.7 | 49.8 | Adjuvant (A) | 2017-03-05 | 2017-03-18 | Cisplatin | N | Y | 330007281 | CISPLATIN |
| 330001848 | 330001053 | 1.82 | 12.8 | Curative (C) | null | 2015-08-24 | Cisplatin | N | Y | 330007281 | CISPLATIN |
| 330001849 | 330001053 | 1.81 | 81 | Curative (C) | 2016-07-14 | 2016-07-20 | Cisplatin | null | Y | 330007281 | CISPLATIN |
| 330001850 | 330001054 | 1.82 | 48.6 | Neo-adjuvant (N) | 2015-06-25 | 2015-06-25 | Cisplatin + Docetaxel +Fluorouracil | N | null | 330007290 | CISPLATIN + DOCETAXEL + FLUOROURACIL |
| 330001851 | 330001055 | 1.65 | 69.3 | null | 2015-03-17 | 2015-04-08 | Cisplatin | 02 | Y | 330007292 | CISPLATIN |
| 330001852 | 330001055 | null | 73.9 | Palliative (P) | null | 2016-09-15 | Trial Unspecified | 1 | N | 330007292 | TRIAL |
| 330001853 | 330001056 | 1.64 | 53.95 | Curative (C) | 2017-09-10 | 2017-10-05 | Cisplatin | N | null | 330007305 | CISPLATIN |
| 330001854 | 330001057 | 0 | 119.4 | Palliative (P) | 2016-06-23 | 2016-06-26 | EW EuroEwing 2012 Arm B VDC | Y | null | 330007306 | TRIAL |
| 330001855 | 330001058 | null | 0 | Curative (C) | 2016-04-06 | 2016-04-07 | EW EuroEwing 2012 Arm A VAC | N | N | 330007307 | NOT MATCHED |
| 330001856 | 330001058 | null | null | Neo-adjuvant (N) | 2015-06-25 | 2015-06-30 | CISPLATIN + DOCETAXEL + FLUOROURACIL | N | N | 330007307 | CISPLATIN + DOCETAXEL + FLUOROURACIL |
| 330001857 | 330001058 | 1.65 | 7.3 | Neo-adjuvant (N) | null | 2015-04-04 | Cisplatin + Docetaxel +Fluorouracil | N | N | 330007307 | CISPLATIN + DOCETAXEL + FLUOROURACIL |
| 330001858 | 330001059 | 1.76 | 96.3 | Curative (C) | 2018-11-13 | 2018-11-16 | Trial Unspecified | Y | N | 330007315 | TRIAL |
| 330001859 | 330001060 | 1.8 | null | Curative (C) | 2017-10-27 | 2017-11-23 | Cisplatin | N | Y | 330007320 | CISPLATIN |
| 330001860 | 330001061 | 1.74 | 75.7 | Curative (C) | 2014-08-02 | 2014-08-02 | Cisplatin + Docetaxel +Fluorouracil | N | N | 330007321 | CISPLATIN + DOCETAXEL + FLUOROURACIL |
| 330001861 | 330001062 | 1.62 | 64.1 | Neo-adjuvant (N) | 2013-12-08 | 2013-12-19 | Cisplatin + Docetaxel +Fluorouracil | null | N | 330007323 | CISPLATIN + DOCETAXEL + FLUOROURACIL |
| 330001862 | 330001063 | 1.8 | 78.6 | Curative (C) | 2016-11-06 | 2016-11-30 | Cisplatin | N | Y | 330007327 | CISPLATIN |